Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-Induced Sleep for Refractory Chronic Insomnia with Anxiety/Depression
ChiCTR2600123150Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in Insomnia, anxiety disorder and major depressive disorder (MDD), sponsored by Liaocheng City People's Hospital. Primary endpoints: Hamilton Anxiety Scale (HAMA) score change and Hamilton Depression Scale (HAMD-24) score change. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
Insomniaanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2600123150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123150.